---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290709823.md"
description: "Sol-Gel Technologies shares are trading higher after Mizuho initiated coverage on the stock with an Outperform rating and announced a $285 price target."
datetime: "2026-06-24T14:14:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290709823.md)
  - [en](https://longbridge.com/en/news/290709823.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290709823.md)
generator: "portal-rs"
---

# 

Sol-Gel Technologies shares are trading higher after Mizuho initiated coverage on the stock with an Outperform rating and announced a $285 price target.

### Related Stocks

- [SLGL.US](https://longbridge.com/en/quote/SLGL.US.md)
- [8411.JP](https://longbridge.com/en/quote/8411.JP.md)
- [MFG.US](https://longbridge.com/en/quote/MFG.US.md)

## Related News & Research

- [Sol-Gel Therapeutics: Steady SGT-610 Execution and Capital-Efficient Growth Strategy Drive Price Target Increase to $195 and Support Buy Rating](https://longbridge.com/en/news/296514505.md)
- [Opaleye Management reports $68,006 purchase of Sol-Gel Technologies common shares](https://longbridge.com/en/news/295970228.md)
- [Pain at the pump could become a major investor headache](https://longbridge.com/en/news/296383272.md)
- [Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy](https://longbridge.com/en/news/296736975.md)
- [Sol-Gel Technologies (SLGL) Initiated with a Buy at Mizuho Securities](https://longbridge.com/en/news/290666760.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**